Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ono Pharmaceutical
Pharma
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Kyowa Kirin ended its autoimmune program after new cancer reports. Sanofi linked up with Sino Biopharm. BioNTech advanced a DualityBio ADC. And more.
Angus Liu
Mar 6, 2026 9:35am
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
Oct 10, 2025 10:55am
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
May 2, 2025 7:58am
Takeda, Sun, Ono—Fierce Pharma Asia
Mar 14, 2025 8:45am
Novo Nordisk, AstraZeneca, Ono—Fierce Pharma Asia
Feb 21, 2025 8:45am
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
Feb 14, 2025 6:24pm
